BlackRock’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.8M Buy
2,358,793
+211,533
+10% +$2.42M ﹤0.01% 2829
2025
Q4
$22.1M Buy
2,147,260
+103,216
+5% +$870K ﹤0.01% 3046
2025
Q3
$11.9M Buy
2,044,044
+21,894
+1% +$128K ﹤0.01% 3365
2025
Q2
$13.6M Buy
2,022,150
+31,297
+2% +$252K ﹤0.01% 3243
2025
Q1
$18M Buy
1,990,853
+16,401
+0.8% +$204K ﹤0.01% 2999
2024
Q4
$34.1M Buy
1,974,452
+151,617
+8% +$2.75M ﹤0.01% 2701
2024
Q3
$29.1M Buy
1,822,835
+128,968
+8% +$2.03M ﹤0.01% 2801
2024
Q2
$24.1M Buy
1,693,867
+207,699
+14% +$2.95M ﹤0.01% 2858
2024
Q1
$21.1M Sell
1,486,168
-16,369
-1% -$231K ﹤0.01% 2965
2023
Q4
$22.7M Buy
1,502,537
+98,134
+7% +$1.45M ﹤0.01% 2944
2023
Q3
$22.2M Sell
1,404,403
-1,403
-0.1% -$22.1K ﹤0.01% 2886
2023
Q2
$21.3M Buy
1,405,806
+1,193,821
+563% +$16.4M ﹤0.01% 3007
2023
Q1
$3.07M Buy
211,985
+23,991
+13% +$320K ﹤0.01% 3855
2022
Q4
$2.54M Buy
187,994
+40,401
+27% +$708K ﹤0.01% 4030
2022
Q3
$2.33M Buy
147,593
+82,594
+127% +$1.05M ﹤0.01% 4112
2022
Q2
$791K Sell
64,999
-380,521
-85% -$2.89M ﹤0.01% 4627
2022
Q1
$4.18M Buy
445,520
+1,094
+0.2% +$11.7K ﹤0.01% 4057
2021
Q4
$7.61M Buy
+444,426
New +$10.8M ﹤0.01% 3814

Other funds holding TRDA